The orthopedic and spine device market is a constantly changing dynamic field and companies at need to stay at the cutting-edge of surgical technique and development to market the most successful products. Expert analysts from Millennium Research Group discuss the…
Spinal Tech
Smith & Nephew CEO David Illingworth plans on retiring in April, according to a Wall Street Journal report.
OrthoPathways Group, a Sarasota, Fla.-based medical device company, pans to launch a new knee system, Stamina Knee, during the second quarter of this year, according to a company news release.
EOS, a Cambridge, Mass.-based imaging company, has received FDA 510(k) clearance of its sterEOS 3D orthopedic imaging work station for use in lower limb applications in patients 15 years and older, according to a company news release.
Biomet has received FDA 510(k) clearance for the Signature Personalized Patient Care System for total knee replacements, according to a company news release.
As insurance companies increasingly resist coverage for spinal fusions, spine device companies such as Medtronic have seen a plateau in sales of spinal device products, according to a Minnesota Post report.
MedShape Solutions, an orthopedic device company based in Atlanta, has introduced the first human clinical use of ExoShape CL, a two-part PEEK Altera interference fixation designed to improve soft tissue graft fixation during ACL reconstructive surgery, according to a company…
The U.S. District Court Judge has ordered a Stipulation of Dismissal for the patent infringement case between InteliFUSE and Biomedical Enterprises following a settlement for an undisclosed amount, according to a company news release.
Integra LifeSciences, a Plainsboro, N.J.-based orthopedic device company, recently launched the Integra Allograft Cancellous Sponge, a compressible bone graft composed entirely of cancellous bone, according to a company news release.
Ortho Development, a Salt Lake City-based orthopedic device company, recently released the Integrated Spine System designed to treat adult degenerative pathologies, according to a company news release.
